BioTheraGene is a member of the CHEO Research Institute.

 
about us services benefits portfolio links contact us
BioTheraGene  
image row
           
  news        
 
May 2004:

BTG starts early stage drug development planning for Toronto-based pharma-
ceutical company.
 


BTG founder to be featured in Biotechnology Focus magazine.

BTG opens downtown Ottawa
office.



BioTheraGene offers U.S. FDA consulting services through our affiliation with
The Biologics Consulting Group (BCG).
 
 
       
©2003 BioTheraGene